Sensus Healthcare, Inc. (SRTS) Operating Margin
- Operating margin · 12 months: Value -75.71%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -75.71% | Operating income / revenue. Period ending 2026-06-30. $-13.26M ÷ $17.51M × 100 ≈ -75.71% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -13.26M USD | Operating Income (Loss) |
| Revenue | 17.51M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 11.14M USD | Cost of Goods and Services Sold |
| Research and development | 6.40M USD | Research and Development Expense |
| Selling, general and administration | 7.51M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-13.26M | $17.51M | $11.14M | $6.40M | $7.51M | -75.71% |
| 2026-03-31 | $-12.02M | $22.53M | $14.03M | $6.76M | $7.71M | -53.34% |
| 2025-12-31 | $-10.31M | $27.48M | $15.62M | $7.78M | $7.87M | -37.50% |
| 2025-09-30 | $-5.43M | $35.61M | $18.53M | $7.46M | $8.53M | -15.26% |
| 2025-06-30 | $-1.37M | $37.56M | $17.96M | $6.50M | $8.18M | -3.64% |
| 2025-03-31 | $2.56M | $39.49M | $17.36M | $5.90M | $7.78M | 6.48% |
| 2024-12-31 | $8.09M | $41.81M | $17.38M | $4.22M | $7.15M | 19.35% |
| 2024-09-30 | $11.94M | $41.31M | (m) | $3.33M | (m) | 28.91% |
| 2024-06-30 | $8.55M | $36.37M | (m) | $3.55M | (m) | 23.52% |
| 2024-03-31 | $5.44M | $31.65M | $12.55M | $3.51M | (m) | 17.20% |
| 2023-12-31 | $-382.00K | $24.41M | $10.35M | $3.68M | (m) | -1.57% |
| 2023-09-30 | $-1.79M | $24.94M | $10.36M | $4.16M | (m) | -7.16% |
| 2023-06-30 | $2.27M | $30.06M | $11.59M | $3.82M | (m) | 7.55% |
| 2023-03-31 | $7.96M | $37.61M | $13.51M | $3.83M | (m) | 21.17% |
| 2022-12-31 | $14.83M | $44.53M | $14.90M | $3.46M | (m) | 33.30% |
| 2022-09-30 | $15.98M | $44.45M | $14.32M | $3.41M | (m) | 35.94% |
| 2022-06-30 | $14.01M | $40.97M | $13.51M | $3.41M | (m) | 34.20% |
| 2022-03-31 | $9.16M | $34.31M | $11.76M | $3.50M | (m) | 26.71% |
| 2021-12-31 | $4.12M | $27.04M | $10.05M | $3.44M | (m) | 15.24% |
| 2021-09-30 | $-941.87K | $19.11M | $7.75M | $3.17M | (m) | -4.93% |
| 2021-06-30 | $-3.42M | $15.21M | $6.37M | $3.37M | (m) | -22.47% |
| 2021-03-31 | $-5.71M | $10.97M | $4.84M | $3.59M | (m) | -52.08% |
| 2020-12-31 | $-8.23M | $9.58M | $4.33M | $4.16M | (m) | -85.98% |
| 2020-09-30 | $-7.51M | $12.99M | $5.51M | $4.26M | (m) | -57.78% |
| 2020-06-30 | $-6.03M | $17.21M | $6.56M | $4.89M | (m) | -35.05% |
| 2020-03-31 | $-3.41M | $23.51M | $8.56M | $5.68M | (m) | -14.52% |
| 2019-12-31 | $-1.97M | $27.26M | $9.71M | $6.42M | (m) | -7.22% |
| 2019-09-30 | $-2.92M | $26.83M | $9.87M | $6.95M | (m) | -10.89% |
| 2019-06-30 | $-2.54M | $27.33M | $10.04M | $7.10M | (m) | -9.29% |
| 2019-03-31 | $-3.08M | $25.91M | $9.62M | $6.73M | (m) | -11.90% |
| 2018-12-31 | $-2.01M | $26.43M | $9.52M | $6.26M | (m) | -7.59% |
| 2018-09-30 | $-2.44M | $24.82M | $8.45M | $6.47M | (m) | -9.82% |
| 2018-06-30 | $-2.98M | $23.28M | $7.87M | $6.26M | (m) | -12.79% |
| 2018-03-31 | $-3.24M | $22.19M | $7.30M | $5.85M | (m) | -14.62% |
| 2017-12-31 | $-3.72M | $20.59M | $6.79M | $5.49M | (m) | -18.06% |
| 2017-09-30 | $-3.30M | $19.00M | $6.17M | $4.52M | (m) | -17.36% |
| 2017-06-30 | $-2.38M | $17.53M | $5.67M | $3.41M | (m) | -13.56% |
| 2017-03-31 | $-1.96M | $16.13M | $5.36M | $2.67M | (m) | -12.16% |
| 2016-12-31 | $-363.12K | $14.81M | $4.97M | $1.82M | (m) | -2.45% |
| 2016-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $-221.26K | $10.27M | $3.69M | $1.47M | (m) | -2.15% |
| 2015-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B |